🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. transdermal nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 small molecule completed

    1 trial

  2. ulodesine

    Biocryst

    Gout

    phase 2 small molecule completed

    1 trial

  3. valoctocogene roxaparvovec

    BioMarin Pharmaceutical Australia Pty Ltd

    Severe Haemophilia A

    phase 2 mab completed

    1 trial

  4. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Alcoholism

    phase 2 small molecule completed

    1 trial

  5. velusetrag dose 1

    Theravance Biopharma Ireland Umited

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  6. vilamakitug

    XBiotech Germany GmbH

    Axial Spondyloarthritis

    phase 2 small molecule active

    1 trial

  7. vistusertib (AZD2014)

    Samsung Bioepis NL B.V.

    Small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  8. vosoritide

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 2 mab active

    1 trial

  9. widow spider antivenom

    BRIGHT MINDS BIOSCIENCES INC.

    Arachnidism

    phase 2 mab completed

    1 trial

  10. xue-fu-zhu-yu capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Qi Stagnation and Blood Stasis Syndrome

    phase 2 small molecule completed

    1 trial

  11. zonisamide

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  12. 1 Nalmefene implant

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Abuse and Addiction

    phase 1 small molecule active

    1 trial

  13. 100 mg GLPG1205

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  14. 100 mg dose of [14C] GLPG0634

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  15. 11C-OMAR

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule completed

    1 trial

  16. 124I-labeled monoclonal antibody Mu 11-1F4

    BRIGHT MINDS BIOSCIENCES INC.

    AL Amyloidosis

    phase 1 mab completed

    1 trial

  17. 15-Valent Pneumococcal Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Pneumonia, Pneumococcal

    phase 1 mab active

    1 trial

  18. 18F-FAPIBiotin

    The First People's Hospital of Lianyungang

    Malignant Neoplasm

    phase 1 small molecule active

    1 trial

  19. 2-4 of the drugs listed below

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Dependence

    phase 1 small molecule completed

    1 trial

  20. 2-4 of the drugs listed below

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  21. 200 mg GLPG0634 as capsules, fasted

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  22. 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Abuse

    phase 1 small molecule terminated

    1 trial

  23. 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 1 small molecule terminated

    1 trial

  24. 400 mg Cannabidiol

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources